Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors

Journal of Urology

Volumn 161, Issue 4, 1999, Pages 1148-1152

  Böhlen, Dominik ^a   Borner, Markus ^a   Sonntag, Roland W ^a   Fey, Martin F ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adjuvant; Chemotherapy; Follow up studies; Germinoma; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0344604538     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61615-X     Document Type: Article

References (37)

1. Cookson, M. S. and Sarosdy, M. F.: Treatment of intratubular germ-cell neoplasia and low-stage testicular cancer. Curr. Opin. Urol., 5: 255, 1995.
2. Donohue, J. P., Thornhill, J. A., Foster, R. S., Rowland, R. G. and Bihrle, R.: Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J. Urol., 149: 237, 1993.
3. Freedman, L. S., Parkinson, M. C., Jones, W. G., Oliver, R. T., Peckham, M. J., Read, G., Newlands, E. S. and Williams, C. J.: Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet, 2: 294, 1987.
4. Nicolai, N. and Pizzocaro, G.: A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J. Urol., 154: 1045, 1995.
5. Read, G., Stenning, S. P., Cullen, M. H., Parkinson, M. C., Horwich, A., Kaye, S. B. and Cook, P. A.: Medical research council prospective study of surveillance for stage I testicular teratoma. J. Clin. Oncol., 10: 1762, 1992.
6. Weissbach, L., Boedefeld, E. A. and Horstmann-Dubral, B.: Surgical treatment of stage-I non-seminomatous germ cell testis tumor. Eur. Urol., 17: 97, 1990.
7. Sturgeon, J. F., Jewett, M. A., Alison, R. E., Gospodarowicz, M. K., Blend, R., Herman, S., Richmond, H., Thomas, G., Duncan, W. and Munro, A.: Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J. Clin. Oncol., 10: 564, 1992.
8. Javadpour, N. and Young, J. D.: Prognostic factors in nonseminomatous testicular cancer. J. Urol., 135: 497, 1986.
9. Hoskin, P., Dilly, S., Easton, D., Horwich, A., Hendry, W. and Peckham, M. J.: Prognostic factors in stage I non-seminomatous germ cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J. Clin. Oncol., 4: 1031, 1986.
10. Weissbach, L. and Bussar-Maatz, R.: Können Risikofaktoren die Strategien im Stadium I des Nicht-Seminoms bestimmen? Akt. Urol., 26: 79, 1995.
11. McLeod, D. G., Weiss, R. B., Stablein, D. M., Muggia, F. M., Paulson, D. F., Ellis, J. H., Spaulding, J. T. and Donohue, J. P.: Staging relationships and outcome in early stage testicular cancer: a report from the testicular cancer intergroup study. J. Urol., 145: 1178, 1991.
12. Mostofi, F. K.: Pathology of germ cell tumors of testis. A progress report. Cancer, 45: 1735, 1980.
13. International Union Against Cancer: Testis. In: TNM Atlas, Classification of Malignant Tumors, 3rd ed. New York: Springer Verlag, p. 251, 1992.
14. Gerson, R., Tellez, B. E., Lazaro, L. M., Sanchez, F. E., Garcia, I. C., Gutierrez, G. F. and Garcia, G. H.: Low toxicity with continuous infusion of high dose bleomycin in poor prognostic testicular cancer. Amer. J. Clin. Oncol., 16: 323, 1993.
15. Studer, U. E., Fey, M. F., Calderoni, A., Kraft, R., Mazzucchelli, L. and Sonntag, R. W.: Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. Eur. Urol., 23: 444, 1993.
16. Bokemeyer, C., Kuczyk, M. A., Serth, J., Hartmann, J. T., Schmoll, H. J., Jonas, U. and Kanz, L.: Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters. J. Cancer Res. Clin. Oncol., 122: 575, 1996.
17. Fernandez, E. B., Moul, J. W., Foley, J. P., Colon, E. and McLeod, D. G.: Retroperitoneal imaging with third and fourth genera-tion computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology, 44: 548, 1994.
18. Williams, S. D., Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., Spaulding, J. T., DeWyss, W. and Crawford, E. D.: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. New Engl. J. Med., 317: 1433, 1987.
19. Einhorn, L. H., Williams, S. D., Loehrer, P. J., Birch, R., Drasga, R., Omura, G. and Greco, A.: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a southeastern cancer study group protocol. J. Clin. Oncol., 7: 387, 1989.
20. Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R. and Donohue, J. P.: Complications of primary retroperitoneal lymph node dissection. J. Urol., 152: 424, 1994.
21. Sandeman, T. F. and Yang, C.: Results of adjuvant chemotherapy for low-stage nonseminomatous germ cell tumors of the testis with vascular invasion. Cancer, 62: 1471, 1988.
22. Studer, U. E., Sonntag, R. W., Calderoni, A., Fey, M. and Zingg, E. J.: Adjuvant chemotherapy in patients with high-risk stage I non seminomatous germ cell tumors. J. Urol., part 2, 147: 335A, abstract 492, 1992.
23. Moul, J. W., McCarthy, W. F., Fernandez, E. B. and Sesterhenn, I. A.: Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I non-seminomatous testicular cancer. Cancer Res., 54: 362, 1994.
24. Oliver, R. T., Raja, M. A., Ong, J. and Gallagher, C. J.: Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients. J. Urol., 148: 1453, 1992.
25. Pont, J., Albrecht, W., Postner, G., Sellner, F., Angel, K. and Höltl, W.: Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. J. Clin. Oncol., 14: 441, 1996.
26. Cullen, M. H., Stenning, S. P., Parkinson, M. C., Fossa, S. D., Kaye, S. B., Horwich, A. H., Harland, S. J., Williams, M. V. and Jakes, R.: Short course adjuvant chemotherapy in high risk stage I nonseminomatous germ-cell tumors of the testis: a medical research council report. J. Clin. Oncol., 14: 1106, 1996.
27. Bajorin, D. F. and Bosl, G. J.: Bleomycin in germ cell tumor therapy: not all regimens are created equal. J. Clin. Oncol., 15: 1717, 1997.
28. Nichols, C. R., Williams, S. D., Loehrer, P. J., Greco, F. A., Crawford, E. D., Weetlaufer, J., Miller, M. E., Bartolucci, A., Schachter, L. and Einhorn, L. H.: Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J. Clin. Oncol., 9: 1163, 1991.
29. Bokemeyer, C. and Schmoll, H.-J.: Treatment of testicular cancer and the development of secondary malignancies. J. Clin. Oncol., 13: 283, 1995.
30. Colls, B. M., Harvey, V. J., Skelton, L., Thompson, P. I. and Frampton, C. M.: Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994. J. Clin. Oncol., 14: 2061, 1996.
31. Lange, P. H., Chang, W. Y. and Fraley, E. E.: Fertility issues in the therapy of nonseminomatous testicular tumors. Urol. Clin. N. Amer., 14: 731, 1987.
32. Fossa, S. D., Aass, N., Ous, S. and Waehre, H.: Long-term morbidity and quality of life in testicular cancer patients. Scand. J. Urol. Nephrol., suppl., 138: 241, 1991.
33. Hansen, S. W., Berthelsen, J. G. and van der Maase, H.: Long-term fertility and leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine and bleomycin versus surveillance. J. Clin. Oncol., 8: 1695, 1990.
34. Lampe, H., Horwich, A., Norman, A., Nicholls, J. and Dearnaley, D. P.: Fertility after chemotherapy for testicular germ cell cancers. J. Clin. Oncol., 15: 239, 1997.
35. Chevreau, C., Soulié, M., Rischmann, P., Plante, P., Malavaud, B., Gaspard, M. H., Suc, E., Couderc, B., Bachaud, J. M. and Bugat, R.: Adjuvant chemotherapy in high risk stage I non-seminomatous germ cell tumors. Proc. American Society of Clinical Oncology, 16: 320a, 1997.
36. Abratt, R. P., Pontin, A. R., Barnes, R. D. and Reddi, B. V.: Adjuvant chemotherapy for stage I non-seminomatous testicular cancer. S. Afr. Med. J., 84: 605, 1994.
37. Ondrus, D., Goncalves, F., Kausitz, J., Mat'oska, J. and Belan, V.: The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors. Neoplasma, 43: 195, 1996.